{"news": [{"date": "20240227081511", "headline": "Boston Scientific Corporation (BSX) Hits Fresh High: Is There Still Room to Run?", "summary": "Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues."}, {"date": "20240227084511", "headline": "Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio", "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage."}, {"date": "20240227104400", "headline": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors", "summary": "Shares of Boston Scientific Corp. shed 0.36% to $66.43 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P..."}, {"date": "20240227151500", "headline": "Boston Scientific Announces Completion of \u20ac2.0 Billion Offering of Senior Notes", "summary": "Boston Scientific Corporation (NYSE: BSX) (the \"Company\") today announced that American Medical Systems Europe B.V., its wholly owned finance subsidiary, has completed a public offering of \u20ac750,000,000 aggregate principal amount of 3.375% notes due 2029 and \u20ac1,250,000,000 aggregate principal amount of 3.500% notes due 2032 (collectively, the \"Notes\"). The Notes are fully and unconditionally guaranteed by the Company. Application has been made for the Notes to be admitted to the Official List of"}, {"date": "20240228050815", "headline": "J&J begins enrolling patients in Laminar LAA pivotal trial", "summary": "The new device is meant to compete with systems offered by Boston Scientific and Abbott that address blood clot risk in atrial fibrillation."}, {"date": "20240228165259", "headline": "These stocks are climbing to record highs in 2024 amid rally", "summary": "Markets may have calmed this week after seeing consecutive gains, but that hasn't stopped stocks from reaching all-time highs in 2024 so far. Yahoo Finance Markets Reporter Jared Blikre breaks down the amount of record-highs while option trading volumes surge. For more expert insight and the latest market action, click\u00a0here\u00a0to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan."}, {"date": "20240228233100", "headline": "Boston Scientific (BSX) Receives a Buy from Wells Fargo", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240229050025", "headline": "Daily record highs across the S&P 500 are telling investors this rally is broadening", "summary": "Despite the Magnificent Seven \u2014 or three\u00a0\u2014 powering the S&P 500, the long list of companies hitting new record highs shows another side of the market concentration conversation."}, {"date": "20240229235800", "headline": "Boston Scientific receives FDA approval for Farapulse PFA System", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240301003200", "headline": "The Hot List: 3 AI Stocks Worth Buying on Weakness", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240301010748", "headline": "US FDA approves Boston Scientific's heart device", "summary": "Boston Scientific said onFriday the U.S. Food and Drug Administration has approved itsdevice to treat a complication of heart disease.(Reporting by Mariam Sunny in Bengaluru; Editing by..."}, {"date": "20240301030000", "headline": "Boston Sci gets FDA approval for Agent in-stent restenosis balloon", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240301052339", "headline": "Boston Scientific gains FDA nod for drug-coated coronary balloon", "summary": "BTIG analyst Marie Thibault said physicians could rapidly adopt the first-of-its-kind device."}, {"date": "20240301055500", "headline": "Boston Scientific Receives FDA Approval for the AGENT\u2122 Drug-Coated Balloon", "summary": "Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT\u2122 Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue."}, {"date": "20240301062102", "headline": "UPDATE 2-US FDA approves Boston Scientific's drug-coated heart device", "summary": "Boston Scientific said on Friday the U.S. FDA had approved its drug-coated device to treat a complication arising from implanting a stent in the heart.  The approval makes the device, branded Agent, the first drug-coated balloon catheter in the U.S. to treat coronary in-stent restenosis (ISR) in patients with a type of heart disease.  ISR involves accumulation of plaque or scar tissue under the stent, causing a previously opened heart vessel to narrow again."}, {"date": "20240301085012", "headline": "Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term", "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores."}, {"date": "20240301103046", "headline": "Why Is Boston Scientific (BSX) Up 2.1% Since Last Earnings Report?", "summary": "Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues."}, {"date": "20240303033500", "headline": "Analysts Conflicted on These Healthcare Names: Boston Scientific (BSX), ANI Pharmaceuticals (ANIP) and Merck & Company (MRK)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240304001800", "headline": "Truist Financial Keeps Their Buy Rating on Boston Scientific (BSX)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240304033148", "headline": "Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon", "summary": "MARLBOROUGH - Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration approval for the AGENT Drug-Coated Balloon , which is indicated to treat coronary..."}, {"date": "20240304102700", "headline": "Boston Scientific (BSX) Grows IC Business With New FDA Nod", "summary": "The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America."}, {"date": "20240304104300", "headline": "Boston Scientific Corp. stock underperforms Monday when compared to competitors despite daily gains", "summary": "Shares of Boston Scientific Corp. inched 0.45% higher to $67.43 Monday, on what proved to be an all-around poor trading session for the stock market, with..."}, {"date": "20240305192600", "headline": "Axonics ticks higher as Boston Scientific reiterates close in 1H24", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240306003600", "headline": "Piper Sandler Keeps Their Buy Rating on Boston Scientific (BSX)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240306104804", "headline": "20 Unhealthiest States in the US", "summary": "In this article, we will be taking a look at the 20 unhealthiest states in the US. If you do not want to learn about the health expenditure in the US, head straight to the 6 Unhealthiest States in the US. The health landscape of the United States is as diverse as its geography, with disparities [\u2026]"}, {"date": "20240306191700", "headline": "BofA upgrades Edwards to buy, says double-digit growth is back", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240306212300", "headline": "Analysts Are Bullish on Top Healthcare Stocks: Viking Therapeutics (VKTX), Boston Scientific (BSX)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240307002500", "headline": "Boston Scientific price target raised by $12 at TD Cowen, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240307040000", "headline": "Boston Scientific Likely Faces FTC Scrutiny on $3.7 Billion Axonics Deal", "summary": "(Bloomberg) -- Boston Scientific Corp.\u2019s proposed $3.7 billion acquisition of medical device maker Axonics Inc. will likely be scrutinized by the US Federal Trade Commission because the companies are the dominant providers of some treatments for urinary incontinence, according to antitrust experts.Most Read from BloombergChemical Linked to Cancer Found in Acne Creams Including Proactiv, ClearasilHow Trump\u2019s Ex-Treasury Chief Landed 2024's Highest-Profile US Bank DealStocks Climb on Bets Fed, ECB"}, {"date": "20240307040300", "headline": "17 Analysts Have This To Say About Boston Scientific", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240308033700", "headline": "Boston Scientific pulls, refiles HSR notification for Axonics deal", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240308103051", "headline": "Envista (NVST) Down 5.8% Since Last Earnings Report: Can It Rebound?", "summary": "Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues."}, {"date": "20240313121715", "headline": "15 Best Stocks Under $100 To Buy Now", "summary": "In this piece, we will take a look at the 15 best stocks under $100 to buy now. If you want to skip our overview of the current stock market climate, then you can take a look at the 5 Best Stocks Under $100 To Buy Now. As the fourth quarter of the 2023 earnings [\u2026]"}, {"date": "20240314042600", "headline": "BSX November 15th Options Begin Trading", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240314074509", "headline": "Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick", "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage."}, {"date": "20240314202100", "headline": "Catalyst Watch:  Fed rates meeting, Nvidia CEO speaks at GTC 2024, Reddit IPO", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240315023500", "headline": "Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240315040000", "headline": "Medtronic\u2019s Sean Salmon on cardiovascular competition, carving out new markets", "summary": "The president of Medtronic\u2019s cardiovascular portfolio talked about renal denervation, a new procedure to reduce blood pressure, and rising competition in cardiac ablation."}, {"date": "20240315065300", "headline": "Axonics (AXNX) Gets CE Mark for Sacral Neuromodulation System", "summary": "Axonics' (AXNX) fourth-generation rechargeable Sacral Neuromodulation system will reduce the frequency of patient recharges significantly. The new form factor ensures ease of use."}, {"date": "20240318072800", "headline": "Boston Scientific (BSX) Global Growth Robust, Macro Issues Ail", "summary": "Boston Scientific (BSX) is consistently registering fast recovery within its MedSurg segment in the post-pandemic period."}, {"date": "20240319052600", "headline": "Insider Sell: EVP & President of Peripheral Interventions Jeffrey Mirviss Sells 14,506 ...", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240321210300", "headline": "Axonics shareholders approve merger with Boston Scientific", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240321215200", "headline": "Axonics shareholders approve $3.7B merger with Boston Sci", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240321234130", "headline": "Medtronic claims win in Axonics patent row, pushes for jury trial", "summary": "New rulings from a U.S. patent appeal board are the latest step in the companies\u2019 intellectual property dispute over sacral neuromodulation devices."}, {"date": "20240322000600", "headline": "Piper Sandler Sticks to Their Buy Rating for Boston Scientific (BSX)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240322043100", "headline": "Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240322100100", "headline": "Axonics Stockholders Approve Merger Agreement with Boston Scientific", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240324222033", "headline": "GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive", "summary": "GE Healthcare Technologies has good near-term and long-term revenue growth prospects. Click here to see why GEHC stock is a Buy."}, {"date": "20240325071500", "headline": "Abbott (ABT) Expands in Canada With First Eterna SCS Use", "summary": "Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology."}, {"date": "20240325193000", "headline": "Scivita Medical Expands Collaboration with Boston Scientific", "summary": "Recently, Scivita Medical Technology Co., Ltd. (\"Scivita Medical\") and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement."}, {"date": "20240325223400", "headline": "Boston Scientific, Scivita Medical expand strategic cooperation arrangement", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240326200900", "headline": "J&J-Shockwave deal makes strategic sense: analysts", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240326212800", "headline": "Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240326215000", "headline": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors despite daily gains", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240327011500", "headline": "Piper says competitive process could materialize for ShockWave", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240327193600", "headline": "If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240327214600", "headline": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240328060300", "headline": "Boston Scientific (BSX) and Scivita Medical Expand Partnership", "summary": "Boston Scientific (BSX) and Scivita Medical announce an expanded strategic cooperation arrangement."}, {"date": "20240329064000", "headline": "10 Health Care Stocks Whale Activity In Today's Session", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240401034900", "headline": "The least shorted S&P 500 stocks as a percentage of float - BofA", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240401060000", "headline": "Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results", "summary": "Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 24 prior to the conference call."}, {"date": "20240401233653", "headline": "Boston Scientific: The Market's Newest Mega-Cap Needs A Breather", "summary": "Boston Scientific is well-positioned to capture secular tailwinds in the healthcare sector with increasing demand for diagnostics. See why BSX stock is a Hold."}, {"date": "20240402031800", "headline": "Looking Into Boston Scientific's Recent Short Interest", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240402053100", "headline": "Insider Sell: EVP, Human Resources Wendy Carruthers Sells 6,983 Shares of Boston Scientific ...", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240402053100", "headline": "Insider Sell: EVP, Global Operations John Sorenson Sells 16,351 Shares of Boston Scientific ...", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240402210400", "headline": "Unveiling 13 Analyst Insights On Boston Scientific", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240402225200", "headline": "Boston Scientific price target raised by $8 at Citi, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240403032700", "headline": "5 Things to Know in Investing This Week", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240403045200", "headline": "Boston Scientific price target raised by $11 at Argus, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240404011000", "headline": "Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240404011500", "headline": "Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info on $3.7B deal", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240404013200", "headline": "Morning Brew: Block Faces Downgrade, Nikola Ramps Up Production, and Tesla's AI Potential", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240404020123", "headline": "Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information", "summary": "By Denny Jacob Boston Scientific and Axonics each received a request for additional information from the Federal Trade Commission regarding a previously agreed upon merger. The medical..."}, {"date": "20240404040356", "headline": "FTC asks Boston Scientific for more info on $3.7B Axonics deal", "summary": "The company has pushed back its expected closing date for the acquisition due to the second request from the Federal Trade Commission."}, {"date": "20240404051600", "headline": "Evercore ISI Keeps Their Buy Rating on Boston Scientific (BSX)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240404054513", "headline": "UPDATE 1-FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal", "summary": "Boston Scientific said on Thursday the U.S. Federal Trade Commission (FTC) has requested additional information from the medical device maker related to its $3.7 billion deal to buy Axonics.  In a regulatory filing, Boston Scientific said Axonics has also received a request for additional information from the FTC and both the companies expect to respond promptly.  Boston said it now expects the deal, announced in January, to be completed in the second half of 2024 following the FTC's request, compared to its previous estimate of first half."}, {"date": "20240404151603", "headline": "11 Overvalued Stocks Insiders are Dumping Now", "summary": "In this article, we will take a detailed look at the 11 Overvalued Stocks Insiders are Dumping Now. For a quick overview of such stocks, read our article 5 Overvalued Stocks Insiders are Dumping Now. Wise investors almost always keep track of corporate insider activity because paying attention to insider sentiment has proven to be a successful strategy several times [\u2026]"}, {"date": "20240404214500", "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240405004207", "headline": "Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash", "summary": "Boston Scientific faces legal challenges and high trading prices in the medical industry. Find out why BSX stock is a Hold."}, {"date": "20240405030600", "headline": "Johnson & Johnson to acquire Shockwave Medical for $13.1B (update)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240407220000", "headline": "Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE\u2122 Nav Pulsed Field Ablation Catheter and FARAVIEW\u2122 Software Module", "summary": "Boston Scientific Corporation (NYSE: BSX) has initiated the NAVIGATE-PF study of the FARAVIEW\u2122 Software Module* when it is used to visualize and track the FARAWAVE\u2122 Nav Pulsed Field Ablation (PFA) Catheter* for the treatment of patients with paroxysmal and persistent atrial fibrillation (AF). The FARAVIEW technology and the FARAWAVE Nav catheter expand the capabilities of the FARAPULSE\u2122 PFA System through integration with our cardiac mapping system."}, {"date": "20240408094016", "headline": "AHCO or BSX: Which Is the Better Value Stock Right Now?", "summary": "AHCO vs. BSX: Which Stock Is the Better Value Option?"}, {"date": "20240409195700", "headline": "Top 10 best performing S&P 500 health care stocks of 2024", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240410024600", "headline": "Boston Scientific (BSX) Receives a Buy from RBC Capital", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240410035907", "headline": "Boston Scientific : Two employees share their passion for helping people with Parkinson\u2019s disease", "summary": "More than 10 million people are living with Parkinson's disease, a progressive disorder that affects the nervous system and parts of the body controlled by nerves. For World Parkinson's Day, hear from..."}, {"date": "20240410073000", "headline": "Boston Scientific (BSX) Faces Rising Costs, Competition", "summary": "With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations."}, {"date": "20240411073100", "headline": "Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable", "summary": "Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions."}, {"date": "20240413230100", "headline": "Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240414230900", "headline": "Integer just upgraded at BofA, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240415003500", "headline": "Boston Scientific price target raised by $2 at BTIG, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240415010700", "headline": "Boston Scientific price target raised by $8 at RBC Capital, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240415203300", "headline": "Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240415220908", "headline": "Welcome Labour Court Decision On Continuity Of Service When Agency Worker Transitioned To Client Employee", "summary": "The Labour Court recently considered whether the seamless transition of an agency worker, from his assignment at a client site to direct employment by the client, meant he had sufficient continuity..."}, {"date": "20240416021307", "headline": "14 Best 52-Week High Stocks To Invest In Now", "summary": "This article delves into the examination of the 14 best 52-week high stocks to buy now. To explore more such companies that meet comparable criteria, go directly to 5 Best 52-Week High Stocks To Buy Now. The outlook for 2024 is positive for the economy and the stock market. Market conditions improved significantly in Q4 [\u2026]"}, {"date": "20240416084400", "headline": "What's in Store for Boston Scientific (BSX) in Q1 Earnings?", "summary": "Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America."}, {"date": "20240416193300", "headline": "Boston Scientific recalls 1,594 Obsidio Embolic devices in U.S.", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240416212200", "headline": "Boston Sci issues corrective recall for Obsidio Embolic over safety concerns", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240416214800", "headline": "Boston Scientific Corp. stock outperforms competitors despite losses on the day", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240417083809", "headline": "FDA classifies recall of Boston Scientific device to treat hemorrhaging as 'most serious'", "summary": "The U.S. Food and DrugAdministration on Wednesday classified a recall of BostonScientific's device used to block blood flow duringexcessive bleeding or hemorrhaging as most serious. ..."}, {"date": "20240417093732", "headline": "FDA classifies recall of Boston Scientific device as 'most serious'", "summary": "The U.S. Food and DrugAdministration on Wednesday classified a recall of BostonScientific's device used to block blood flow duringexcessive bleeding or hemorrhaging as most serious. ..."}, {"date": "20240417133732", "headline": "UPDATE 1-FDA classifies recall of Boston Scientific device as 'most serious'", "summary": "The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's device used to block blood flow during excessive bleeding or hemorrhaging as \"most serious\".  An investigation showed that Boston's device, Obsidio Embolic, when used with a specific technique posed a higher risk of bowel ischemia during procedures to stop gastrointestinal (GI) bleeding, the agency said.  Bowel ischemia describes disorders that occur when blood flow to your intestines decrease, causing severe abdominal pain."}, {"date": "20240418035700", "headline": "Boston Scientific recalls blood-blocking agent linked to 2 deaths", "summary": "Seven injuries and 11 incidents were also\u00a0associated with the safety issue."}, {"date": "20240418051400", "headline": "BofA\u2019s US 1 List - New additions include CSCO, GS and SPGI", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240418100235", "headline": "FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'", "summary": "On Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recalled Obsidio Embolic by issuing a correction. The FDA has identified this as a Class I recall, the most severe type of recall. An investigation determined that delivery of Obsidio Embolic using the aliquot technique, a commonly used delivery method in embolization procedures, for lower gastrointestinal (GI) bleeding embolization, implies a high risk of bowel ischemia. The most serious and the most common adverse health consequenc"}, {"date": "20240419071525", "headline": "Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics", "summary": "Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024."}, {"date": "20240420060300", "headline": "THQ: Collecting A High Yield From Increased Medical Spending", "summary": "abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield and exposure to diverse healthcare subsectors, outperforming peers. Explore more here."}, {"date": "20240420224900", "headline": "Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422005700", "headline": "Stryker added to 'Tactical Outperform' list at Evercore ISI", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240422191400", "headline": "Boston Scientific Q1 2024 Earnings Preview", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423033000", "headline": "Baron Health Care Fund Q1 2024 Shareholder Letter", "summary": "In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared with the 8.52% gain for the Russell 3000 Health Care Index and the 10.56% gain for the S&P 500 Index."}, {"date": "20240423033200", "headline": "Notable earnings before Wednesday's open", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423041400", "headline": "Boston Scientific, Dexcom and Edwards next as earnings season rolls on", "summary": "J.P. Morgan analysts expect this week\u2019s results to be \u201cvery good\u201d following reports from J&J, Abbott and Intuitive Surgical."}, {"date": "20240423041700", "headline": "Blackstone Explores Joint Ventures and Strengthens Finances", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423061800", "headline": "Notable companies reporting before tomorrow's open", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423093600", "headline": "What's in Store for These 4 Medical Products Stocks in Q1 Earnings?", "summary": "Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time."}, {"date": "20240423190300", "headline": "Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423190600", "headline": "Buy Rating for Boston Scientific: Strong Q1 Performance and Promising Cardiology Pipeline Fuel Optimism", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423211600", "headline": "Boston Scientific: Strong Q1 Performance and Raised Forecasts Bolster Buy Rating", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423213100", "headline": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and CureVac (CVAC)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423213600", "headline": "Stock market today: Asian benchmarks mostly slide as investors focus on earnings", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423233400", "headline": "Boston Scientific Non-GAAP EPS of $0.56 beats by $0.05, revenue of $3.86B beats by $180M", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240423233900", "headline": "Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424000000", "headline": "Volato Announces Changes to Board Composition", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424000000", "headline": "Boston Scientific\u2019s stock jumps 2.7% after earnings top estimates", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424000000", "headline": "Boston Scientific reports Q1 adjusted EPS 56c, consensus 51c", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424000200", "headline": "Boston Scientific sees Q2 adjusted EPS 57c-59c, consensus 56c", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424000400", "headline": "Boston Scientific sees FY24 adjusted EPS $2.29-$2.34, consensus $2.25", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424004012", "headline": "Boston Scientific: Q1 Earnings Snapshot", "summary": "MARLBOROUGH, Mass. \u2014 MARLBOROUGH, Mass. \u2014 Boston Scientific Corp. on Wednesday reported first-quarter profit of $495 million. On a per-share basis, the Marlborough, Massachusetts-based..."}, {"date": "20240424010313", "headline": "Boston Scientific Lifts 2024 Outlook After Strong 1Q", "summary": "By Dean Seal Boston Scientific has raised its earnings and sales guidance for 2024 after logging a higher profit and stronger-than-expected revenue growth in the first three months of the..."}, {"date": "20240424014000", "headline": "Artisan Global Opportunities Fund Q1 2024 Commentary", "summary": "Artisan Global Opportunities Fund portfolio outperformed the MSCI AC World Index in Q1 2024 due to broad-based positive security selection. Click here to read more."}, {"date": "20240424014100", "headline": "Boston Scientific\u2019s stock jumps premarket as earnings shine and company offers upbeat guidance", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424015100", "headline": "Fly Intel: Pre-market Movers", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424020928", "headline": "Boston Scientific Corporation 2024 Q1 - Results - Earnings Call Presentation", "summary": "The following slide deck was published by Boston Scientific Corporation in conjunction with their 2024 Q1 earnings call."}, {"date": "20240424021200", "headline": "Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Boston Scientific (BSX) and Biogen (BIIB)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424025000", "headline": "Artisan Global Discovery Fund Q1 2024 Commentary", "summary": "Artisan Global Discovery Fund portfolio outperformed the MSCI AC World Index in Q1 2024. Click here to read the full letter."}, {"date": "20240424035500", "headline": "BSX Stock Earnings: Boston Scientific Beats EPS, Beats Revenue for Q1 2024", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424040000", "headline": "Boston Scientific gives first look at Farapulse US rollout", "summary": "CEO Mike Mahoney would not provide specific sales numbers for the device, but hyped the pulsed field ablation system as the \u201cmost transformational product\u201d he\u2019s seen in his time with the company."}, {"date": "20240424042000", "headline": "Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424043000", "headline": "Boston Scientific Announces Results for First Quarter 2024", "summary": "Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $495 million or $0.33 per share (EPS), compared to $300 million or $0.21 per share a year ago, and achieved adjusted3 EPS of $0.56 for"}, {"date": "20240424045800", "headline": "Boston Scientific hits 52-week high on Q1 beat", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424050300", "headline": "Boston Scientific\u2019s stock heads for record high as earnings shine and company offers upbeat guidance", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424051526", "headline": "Boston Scientific Corporation (BSX) Q1 2024 Earnings Call Transcript", "summary": "Boston Scientific Corporation (NYSE:NYSE:BSX) Q1 2024 Earnings Conference Call April 24, 2024 8:00 AM ETCompany ParticipantsJon Monson - Senior Vice..."}, {"date": "20240424054005", "headline": "Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates", "summary": "Boston Scientific (BSX) delivered earnings and revenue surprises of 9.80% and 4.85%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?"}, {"date": "20240424055139", "headline": "Boston Scientific Corp (BSX) Q1 2024 Earnings: Surpasses Analyst Revenue Forecasts and EPS Estimates", "summary": "Comprehensive Analysis of Boston Scientific's First Quarter Financial Performance"}, {"date": "20240424061800", "headline": "Texas Instruments, Mattel rise; General Dynamics, Teledyne fall, Wednesday, 4/24/2024", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424063000", "headline": "Boston Scientific Stock Rises on More Than Just an Earnings Beat", "summary": "FEATURE  Shares of Boston Scientific were trading higher after the medical-device company topped quarterly estimates and issued strong guidance. For its first quarter, Boston Scientific \u00a0reported adjusted earnings per share of 56 cents, higher than the 51 cents Wall Street had expected, according to FactSet."}, {"date": "20240424064500", "headline": "Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424065400", "headline": "Boston Scientific price target raised by $13 at Stifel, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424080005", "headline": "Boston Scientific (BSX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates", "summary": "Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers."}, {"date": "20240424084227", "headline": "The Bullish First-Quarter Report That Helped Boston Scientific Break Out \u2014 Twice", "summary": "Boston Scientific made a bullish move Wednesday morning, topping two buy points on a solid first-quarter report."}, {"date": "20240424091605", "headline": "Here\u2019s Why Boston Scientific Corporation (BSX) Rose in Q1", "summary": "Baron Funds, an investment management company, released its \u201cBaron Health Care Fund\u201d first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P [\u2026]"}, {"date": "20240424094006", "headline": "AHCO vs. BSX: Which Stock Is the Better Value Option?", "summary": "AHCO vs. BSX: Which Stock Is the Better Value Option?"}, {"date": "20240424095446", "headline": "Top Midday Stories: Tesla, Boston Scientific Shares Jump Post-Earnings; Major Airline Stocks Down on New DOT Rules; B. Riley Finally Submits 10-K, Sends Stock Soaring", "summary": "Top Midday Stories: Tesla, Boston Scientific Shares Jump Post-Earnings; Major Airline Stocks Down on New DOT Rules; B. Riley Finally Submits 10-K, Sends Stock Soaring"}, {"date": "20240424104000", "headline": "Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised", "summary": "Barring Neuromodulation, organic and operational revenues at Boston Scientific's (BSX) core business segments rise in the first quarter."}, {"date": "20240424124234", "headline": "Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars", "summary": "Boston Scientific Corporation (NYSE:BSX) shares are trading higher on Wednesday after the company reported better-than-expected first-quarter earnings and issued guidance. The company generated first-quarter revenues of $3.86 billion, beating the consensus estimate of $3.69 billion. Sales soared 13.8% year-over-year on a reported basis, 15% on an operational basis, and 13.1% on an organic basis, beating the management guidance of approximately 7.5%-9.5% on a reported basis and approximately 7%-9"}, {"date": "20240424193500", "headline": "(BSX) - Analyzing Boston Scientific's Short Interest", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424212105", "headline": "Q1 2024 Boston Scientific Corp Earnings Call", "summary": "Q1 2024 Boston Scientific Corp Earnings Call"}, {"date": "20240424224000", "headline": "Boston Scientific (BSX) Poised for Growth: A Buy Recommendation Amid Strong Q1 Performance and Strategic Acquisitions", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424224400", "headline": "Boston Scientific: Strong Q1 Performance and Promising Future Drive Buy Rating", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424232300", "headline": "Boston Scientific price target raised by $10 at Wells Fargo, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424233000", "headline": "Boston Scientific price target raised by $5 at Baird, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424233800", "headline": "Boston Scientific price target raised by $5 at Mizuho, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424234800", "headline": "Boston Scientific price target raised by $6 at Citi, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240424235600", "headline": "Boston Scientific (BSX) Gets a Buy from RBC Capital", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425000000", "headline": "Boston Scientific price target raised by $2 at Canaccord, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425001000", "headline": "Boston Scientific (BSX) Receives a Buy from Truist Financial", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425010113", "headline": "Boston Scientific Corp (BSX) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and ...", "summary": "Explore key financial outcomes and strategic discussions from Boston Scientific's first quarter of 2024 earnings call."}, {"date": "20240425010700", "headline": "Key Takeaways From Boston Scientific Analyst Ratings", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425012500", "headline": "Boston Scientific price target raised by $6 at Evercore ISI, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425012600", "headline": "Boston Scientific price target raised by $12 at Raymond James, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425015100", "headline": "Boston Scientific price target raised by $10 at Deutsche Bank, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425024600", "headline": "BSX Crosses Above Average Analyst Target", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425025400", "headline": "Boston Scientific price target raised by $4 at RBC Capital, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425062000", "headline": "Upcoming Deadline to Share in Boston Scientific Corporation (BSX) Class Action Settlement", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425074504", "headline": "Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term", "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores."}, {"date": "20240425082546", "headline": "Boston Scientific Corporation (NYSE:BSX) Q1 2024 Earnings Call Transcript", "summary": "Boston Scientific Corporation (NYSE:BSX) Q1 2024 Earnings Call Transcript April 24, 2024 Boston Scientific Corporation isn\u2019t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Boston Scientific First Quarter 2024 Earnings Call. All participants will be [\u2026]"}, {"date": "20240425093424", "headline": "20 Fastest Growing Health Tech Companies in the World", "summary": "In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital [\u2026]"}, {"date": "20240425214800", "headline": "Barclays Reaffirms Their Buy Rating on Boston Scientific (BSX)", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240425220500", "headline": "Boston Scientific price target raised by $8 at Barclays, here's why", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240426011500", "headline": "Top 4 Health Care Stocks That May Plunge This Month", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240426054505", "headline": "Making sustainable progress for people and the planet: Our 2023 Performance Report", "summary": "Improving patient health is the cornerstone of everything we do at Boston Scientific. Whether it's innovating care to help people live longer, better lives; empowering people by advancing diversity,..."}, {"date": "20240426075011", "headline": "Here's Why Boston Scientific (BSX) is a Strong Momentum Stock", "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service."}, {"date": "20240429052000", "headline": "The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp", "summary": "10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp are included in this Analyst Blog."}, {"date": "20240429065600", "headline": "Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240429074011", "headline": "Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?", "summary": "Here is how Boston Scientific (BSX) and Canopy Growth Corporation (CGC) have performed compared to their sector so far this year."}, {"date": "20240429103300", "headline": "Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down", "summary": "Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance."}, {"date": "20240430102600", "headline": "QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand", "summary": "QIAGEN (QGEN) Q1 results are driven by solid growth in consumables and ongoing higher instruments placements."}, {"date": "20240430103500", "headline": "Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise", "summary": "Ecolab's (ECL) robust performance across the majority of its segments drives its first-quarter sales despite business challenges."}, {"date": "20240430122918", "headline": "Boston Scientific Shares Tracking Higher", "summary": "Boston Scientific Corporation (BSX) shares are up 25% so far in 2024. Looking under the surface, it\u2019s clear to see why this medical technology stock is gaining."}, {"date": "20240501020000", "headline": "Boston Scientific Announces Upcoming Investor Conference Schedule", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240501021200", "headline": "Catheter Precision appoints Marie-Claude Jacques as CCO", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240501053700", "headline": "$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240501064400", "headline": "Cencora (COR) Q2 Earnings Top Estimates, 2024 View Raised", "summary": "Cencora's (COR) second-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains."}, {"date": "20240501085900", "headline": "Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises", "summary": "Inari Medical's (NARI) first-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the companies continue to incur operating losses."}, {"date": "20240501091600", "headline": "CVS Health's (CVS) Q1 Earnings Miss Estimates, Margins Up", "summary": "CVS Health's (CVS) Q1 performance is impacted by a decline in the Health Services segment due to continued pharmacy client price improvements."}, {"date": "20240501104700", "headline": "Merit Medical (MMSI) Q1 Earnings Top Estimates, Margins Up", "summary": "Merit Medical (MMSI) benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter."}, {"date": "20240501225145", "headline": "Boston Scientific (BSX) Price Target Increased by 11.024% to 83.241", "summary": ""}, {"date": "20240502000800", "headline": "Needham Just Boosted Its Price Target on These 3 Stocks", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240502071400", "headline": "Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y", "summary": "Glaukos' (GKOS) first-quarter 2024 results showcase growth in revenues while earnings miss the Zacks consensus Estimate. Loss at the operating level raises concern as well."}, {"date": "20240502071600", "headline": "Accuray (ARAY) Q3 Earnings Lag Estimates, Gross Margin Contracts", "summary": "Despite strength in radiation oncology, Accuray (ARAY) reports dismal third-quarter fiscal 2024 results."}, {"date": "20240502072500", "headline": "BD (BDX) Q2 Earnings Surpass Estimates, FY24 View Revised", "summary": "BD's (BDX) overall top line benefits from revenue growth in all segments and both geographic regions in the fiscal second quarter."}, {"date": "20240502080300", "headline": "Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised", "summary": "Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products."}, {"date": "20240502080300", "headline": "Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View", "summary": "Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024."}, {"date": "20240502084200", "headline": "Reasons to Retain Quest Diagnostics (DGX) Stock for Now", "summary": "Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth."}, {"date": "20240502085400", "headline": "Envista (NVST) Q1 Earnings Miss Estimates, Margins Down", "summary": "Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024."}, {"date": "20240502095400", "headline": "Zimmer Biomet (ZBH) Q1 Earnings Beat, Margins Expand", "summary": "Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER."}, {"date": "20240502110500", "headline": "DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y", "summary": "DENTSPLY SIRONA's (XRAY) first-quarter 2024 results showcase a decline in year-over-year sales with an improved bottom line."}, {"date": "20240502230655", "headline": "Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)", "summary": "A Strategic SWOT Insight into Boston Scientific's Performance and Market Position"}, {"date": "20240503013800", "headline": "Belo Sun Mining Appoints New Interim CEO", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240503020000", "headline": "Belo Sun Mining Announces Changes to Executive Leadership", "summary": "Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results."}, {"date": "20240503075300", "headline": "GE Healthcare's (GEHC) Revolution RT to Aid Cancer Treatment", "summary": "GE Healthcare (GEHC) unveils Revolution RT, along with other upgrades, from its portfolio during the ESTRO 2024 Congress."}, {"date": "20240503092909", "headline": "Boston Scientific : Bridging gaps in care for the Asian-American community", "summary": "As a leader in health care, Boston Scientific is committed to improving patient outcomes and helping to create a healthier world. This work includes addressing the vast inequities in care that exist..."}, {"date": "20240503101300", "headline": "Teleflex (TFX) Q1 Earnings Beat Estimates, Margins Rise", "summary": "Teleflex's (TFX) first-quarter 2024 results reflect growth across the majority of the company's product families in EMEA."}, {"date": "20240503102200", "headline": "Bruker (BRKR) Q1 Earnings Surpass Estimates, Margins Decline", "summary": "Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024."}, {"date": "20240503102200", "headline": "DaVita (DVA) Q1 Earnings & Revenues Top Estimates, Margins Up", "summary": "DaVita's (DVA) robust segmental revenues drive its first-quarter performance."}, {"date": "20240503102400", "headline": "Lantheus (LNTH) Q1 Earnings Surpass Estimates, Gross Margin Up", "summary": "Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance."}, {"date": "20240503102900", "headline": "Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up", "summary": "Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management."}, {"date": "20240503111200", "headline": "Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up", "summary": "Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate."}, {"date": "20240503111400", "headline": "Avanos (AVNS) Q1 Earnings & Revenues Surpass Estimates", "summary": "Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues."}]}